• Strides Pharma notified exchanges of audio recording availability for its May 18, 2026 earnings call discussing FY26 results.
• The call was held at 17:00 IST to review audited financial results for Q4 and full year ended March 31, 2026.
• Recording is available on the company's investor relations website under quarterly results section.
• Disclosure was made pursuant to SEBI LODR Regulations 46 and 30 for compliance purposes.